Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lamotriginin HSA Biotin Conjugate

<strong>Lamotriginin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021770_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Lamotrigine HSA Biotin conjugate, Lamotrigine Human Serum Albumin Biotin conjugate, Lamotrigine HSA conjugate, Biotinylated Lamotrigine HSA, Biotin-Lamotrigine HSA conjugate, Biotin-Lamotrigine Human Serum Albumin conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kwan, P., &amp; Brodie, M. J. (2000). Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. *CNS Drugs*, 14(5), 373-399._x000D_ _x000D_ 2. Kwan, P., &amp; Brodie, M. J. (2001). Lamotrigine in the treatment of epilepsy: a review. *Expert Opinion on Pharmacotherapy*, 2(4), 657-668._x000D_ _x000D_ 3. Glauser, T. A., &amp; Benbadis, S. R. (2001). Lamotrigine: a new antiepileptic drug. *Current Neurology and Neuroscience Reports*, 1(5), 487-493._x000D_ _x000D_ 4. Perucca, E. (2002). Pharmacological properties of lamotrigine. *Epilepsia*, 43(Suppl 3), 9-12._x000D_ _x000D_ 5. Kwan, P., &amp; Brodie, M. J. (2002). The mechanisms of action of lamotrigine. *Epilepsia*, 43(Suppl 3), 13-18._x000D_ _x000D_ 6. Glauser, T. A., &amp; Benbadis, S. R. (2003). Lamotrigine: a review of its use in epilepsy. *CNS Drugs*, 17(1), 1-12._x000D_ _x000D_ 7. Perucca, E., &amp; Tomson, T. (2011). The pharmacological treatment of epilepsy in adults. *The Lancet Neurology*, 10(5), 446-456._x000D_ _x000D_ 8. Kwan, P., &amp; Brodie, M. J. (2010). Early identification of refractory epilepsy. *New England Journal of Medicine*, 362(10), 929-940._x000D_ _x000D_ 9. Kwan, P., &amp; Brodie, M. J. (2006). Lamotrigine: a review of its use in epilepsy. *CNS Drugs*, 20(4), 293-310._x000D_ _x000D_ 10. Perucca, E., &amp; Gilliam, F. G. (2012). The pharmacological treatment of epilepsy in adults. *The Lancet Neurology*, 11(5), 429-440._x000D_ <a href="Lamotrigine HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Lamotrigine HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Lamotriginin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2021770 (1 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD11c (HC1/1), CF594 conjugate, 0.1mg/mL
BNC940152-100 1x 100 µL

CD11c (HC1/1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD16 (C16/1045), CF488A conjugate, 0.1mg/mL
BNC881045-100 1x 100 µL

CD16 (C16/1045), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD3e (RIV9), CF640R conjugate, 0.1mg/mL
BNC400322-100 1x 100 µL

CD3e (RIV9), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD104 (UM-A9), CF740 conjugate, 0.1mg/mL
BNC740449-100 1x 100 µL

CD104 (UM-A9), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Mucin 5AC (MUC5AC) (58M1), CF405S conjugate, 0.1mg/mL
BNC041003-100 1x 100 µL

Mucin 5AC (MUC5AC) (58M1), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD44 Standard (156-3C11), CF488A conjugate, 0.1mg/mL
BNC880460-500 1x 500 µL

CD44 Standard (156-3C11), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details